Table 4.
Case | Age (yr) | Cancer | Stage | Detected in blood and/or matched normal tissue |
Detected in tumor |
Germline/Somatic | Family historya) | ||
---|---|---|---|---|---|---|---|---|---|
Gene | Mutation | Gene | Mutation | ||||||
OCA07 | 53 | Ovary | III | BRCA1 | c.2048delA | BRCA1 | c.2048delA | Germline | + |
Pat55 | 59 | Ovary | III | BRCA1 | c.2359delG | BRCA1 | c.2359delG | Germline | – |
OCA02 | 47 | Ovary | III | BRCA1 | c.928C>T | BRCA1 | c.928C>T | Germline | – |
Pat10 | 53 | Ovary | III | BRCA1 | c.1716dupA | BRCA1 | c.1716dupA | Germline | + |
Pat48 | 64 | Ovary | III | BRCA1 | c.3442G>T | BRCA1 | c.3442G>T | Germline | + |
Pat20 | 52 | Ovary | III | BRCA1 | c.3700_3704delGTAAA | BRCA1 | c.3700_3704delGTAAA | Germline | + |
Pat45 | 61 | Ovary | III | BRCA1 | c.922_924delAGCinsT | BRCA1 | c.922_924delAGCinsT | Germline | + |
Pat21 | 55 | Ovary | III | BRCA1 | c.4801A>T | BRCA1 | c.4801A>T | Germline | + |
Pat46 | 47 | Ovary | III | BRCA1 | c.390C>A | BRCA1 | c.390C>A | Germline | + |
Pat11 | 65 | Ovary | III | BRCA1 | c.390C>A | BRCA1 | c.390C>A | Germline | + |
Pat05 | 77 | Ovary | IV | BRCA2 | c.3860delA | BRCA2 | c.3860delA | Germline | + |
Pat08 | 55 | Ovary | III | BRCA2 | c.5576_5579delTTAA | BRCA2 | c.5576_5579delTTAA | Germline | + |
OCA18 | 57 | FTC | III | BRCA1 | c.3895C>T | BRCA1 | c.3895C>T | Germline | + |
OCA13 | 43 | PPC | III | BRCA1 | c.3813dupT | BRCA1 | c.3813dupT | Germline | – |
Pat41 | 58 | Ovary | III | BRCA1 | c.5496_5506delinsA | BRCA1 | c.5496_5506delinsA | Germline | + |
Pat49 | 48 | Ovary | III | BRCA1 | c.390C>A | BRCA1 | c.390C>A | Germline | – |
Pat47 | 49 | Ovary | III | Not detected | BRCA1 | c.4287C>A | Somatic | – | |
OCA16 | 55 | Ovary | IV | Not detected | BRCA1 | c.969_970delAA | Somatic | – | |
OCA19 | 52 | FTC | III | Not detected | BRCA1 | c.1813delG | Somatic | + | |
OCA14 | 50 | PPC | III | Not detected | BRCA2 | c.547delA | Somatic | + |
FTC, fallopian tubal cancer; PPC, primary peritoneal cancer.
Family history of BRCA-related cancer within second degree relatives and/or patient history of breast cancer.